Biogenesis of γ-secretase early in the secretory pathway by Kim, Jinoh et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
JCB: ARTICLE
© The Rockefeller University Press    $30.00
The Journal of Cell Biology, Vol. 179, No. 5, December 3, 2007 951–963
http://www.jcb.org/cgi/doi/10.1083/jcb.200709012
JCB 951
Introduction
Alzheimer’s disease (AD) is a neurodegenerative disorder char-
acterized by the presence of amyloid plaques and neurofi  bril-
lary tangles in hippocampal regions of the brain. A major 
con stituent  of  the amyloid plaque is a small Aβ peptide frag-
ment derived from the β-amyloid precursor protein (APP). APP is 
cleaved along the secretory pathway by several proteases, two of 
which, the β- and γ-secretases, normally generate a 40-amino 
acid long Aβ40 peptide. Abnormal cleavage by γ-secretase 
yields an aggregation-prone 42-amino acid long Aβ42 peptide 
that builds up over time to form neuritic plaques. Mutations in 
APP and presenilin 1 and 2 (PS1 and PS2) account for most of 
the familial forms of AD (FAD), which lead to early onset of the 
disease. These mutations either enhance the ratio of Aβ42/Aβ40 
or increase the level of both Aβ42 and Aβ40 without changing the 
ratio (for review see Walsh and Selkoe, 2004).
Presenilin (PS) is believed to be the catalytic subunit of 
γ-secretase. γ-Secretase is a multi-subunit protein complex whose 
minimal components are nicastrin (NCT), anterior pharynx-1 
(APH-1), presenilin enhancer-2 (PEN-2), and PS (Yu et al., 2000; 
Francis et al., 2002; Goutte et al., 2002; LaVoie et al., 2003; 
Luo et al., 2003; Takasugi et al., 2003). Other possible regulatory 
components of γ-secretase, such as CD147 and TMP21, have 
been reported (Zhou et al., 2005; Chen et al., 2006). Although 
not essential, these regulator proteins affect Aβ production. There-
fore, the assembly and activation of γ-secretase may be linked to 
processing and misprocessing of APP.
Early secretory compartments such as endoplasmic retic-
ulum (ER), ER-Golgi intermediate compartment (ERGIC), and 
cis-Golgi play a critical role in the synthesis, assembly, and quality 
control inspection of multi-subunit membrane protein com-
plexes (Ellgaard et al., 1999). In the case of γ-secretase, retrieval 
of unassembled Pen-2 and NCT, subunits of γ-secretase, is regula-
ted by Rer1 at the cis-Golgi (Kaether et al., 2007; Spasic et al., 
2007). Down-regulation of Rer1 causes an increase of γ-secretase 
at cell surface. Thus, abnormal assembly and traffi  c of γ-secretase 
in the early secretory pathway may impact γ-secretase function 
in later compartments.
Proteins traverse the secretory pathway in defi  ned trans-
port carriers, the fi  rst of which, COPII vesicles, conveys newly 
synthesized and assembled proteins from the ER to the ERGIC 
(Schekman and Orci, 1996). However, because these COPII 
vesicles are transient, it is diffi  cult to analyze the molecular 
characteristics of protein intermediates in cells. Such intermedi-
ates may be evaluated by generating transport vesicles in vitro. 
We exploited a biochemical assay to monitor the export of 
γ-secretase components from the ER (Kim et al., 2005). 
Biogenesis of γ-secretase early in the secretory 
pathway
Jinoh Kim,
1 Bertrand Kleizen,
1 Regina Choy,
1 Gopal Thinakaran,
2 Sangram S. Sisodia,
2 and Randy W. Schekman
1
1Department of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA 94720
2Department of Neurobiology, Pharmacology, and Physiology, University of Chicago, Chicago, IL 60637
𝗄
-Secretase is responsible for proteolytic maturation 
of signaling and cell surface proteins, including am-
yloid precursor protein (APP). Abnormal processing 
of APP by γ-secretase produces a fragment, Aβ42, that 
may be responsible for Alzheimer’s disease (AD). The bio-
genesis and trafﬁ  cking of this important enzyme in relation 
to aberrant Aβ processing is not well deﬁ  ned. Using a cell-
free reaction to monitor the exit of cargo proteins from the 
endoplasmic reticulum (ER), we have isolated a transient 
intermediate of γ-secretase. Here, we provide direct evi-
dence that the γ-secretase complex is formed in an in-
active complex at or before the assembly of an ER transport 
vesicle dependent on the COPII sorting subunit, Sec24A. 
Maturation of the holoenzyme is achieved in a subsequent 
compartment. Two familial AD (FAD)–linked PS1 variants 
are inefﬁ  ciently packaged into transport vesicles generated 
from the ER. Our results suggest that aberrant trafﬁ  cking 
of PS1 may contribute to disease pathology.
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Figure 1. Packaging  of  the  𝗄-secretase complex into COPII vesicles. (A) Standard COPII vesicle formation assay. Sar1 T39N is a GDP-restricted form of 
Sar1a. Cyt represents cytosol (4 mg/ml) and Nuc represents an ATP regenerating system and GTP. (B) Immunoblots of microsomal lysates from N2a cells 
expressing human PS1 variants. Detergent lysates were analyzed by BN-PAGE and probed for the γ-secretase subunits. Either 1% DIG or 0.5% DDM was 
used to prepare detergent lysates. Monoclonal anti-NCT antibody (9C3) was used to detect NCT. The contrast of the PEN-2 panel was adjusted to detect 
faint bands. The speciﬁ   city of anti-PS1-NTF antibody is shown in Fig. S2 (available at http://www.jcb.org/cgi/content/full/jcb.200709012/DC1). 
(C) Constituents of γ-secretase subcomplexes (band I through VI) essentially based on Fraering et al. (2004). (D) A large scale (0.5 ml) vesicle formation re-
action was performed using microsomes from N2a cells expressing human WT PS1 and membranes were solubilized with HN buffer containing 1% DIG for 
BN-PAGE. Polyclonal anti-PS1 NTF antibody was used to detect PS1. The asterisk represents a PS1-containing subcomplex.γ-SECRETASE IN COPII VESICLES • KIM ET AL. 953
COPII proteins (coat protein complex II; Sar1, Sec13/31, 
and Sec23/24) assemble on the surface of the ER and capture 
proteins into vesicles at ER exit sites. The selection of cargo 
proteins at ER export sites is driven by the direct or indirect 
  interaction of cargo proteins with the Sec24 subunit of the coat 
(Lee et al., 2004). In this paper, we describe the characteristics of 
the γ-secretase complex as it assembles in COPII vesicles in mem-
branes harboring wild-type (WT) or FAD mutant forms of PS1.
Results
The 𝗄-secretase complex in the 
COPII vesicle
COPII vesicles budded from microsomal membranes incubated 
with nucleotide and cytosol as a source of COPII proteins. 
ER membranes and transport vesicles were separated by differ-
ential centrifugation (Kim et al., 2005). As a control, an ER res-
ident protein, ribophorin I, was not released into the slowly 
sedimenting transport vesicle fraction (Fig. 1 A). In contrast, an 
ER-to-Golgi recycling protein, p58/ERGIC53/LMAN1, was 
released into the vesicle fraction in a cytosol- and nucleotide-
dependent manner (Fig. 1 A). Furthermore, this cargo release 
was inhibited by a dominant-negative form (T39N) of Sar1 but 
not by Brefeldin A (Fig. 1 A; Fig. S1, available at http://www
.jcb.org/cgi/content/full/jcb.200709012/DC1), suggesting that 
COPII vesicles are responsible for cargo capture.
To study incorporation of PS1 into the γ-secretase complex, 
we fi  rst analyzed γ-secretase from the microsomal membranes. 
For γ-secretase complex analysis, digitonin (DIG) or n-dodecyl 
β-D-maltoside (DDM) was used to solubilize microsomes from 
N2a cells stably expressing PS1 WT or PS1 ∆E9, a FAD-linked 
mutation (Crook et al., 1998). The resultant mixtures were subject 
to BN-PAGE (Fig. 1 B). A summary of γ-secretase subcomplexes 
is described in Fig. 1 C (Fraering et al., 2004). The γ-secretase 
complexes (band VI) from DIG-solubilized microsomes migrated 
more slowly than complexes from DDM solubilized material, but 
in each case all four γ-secretase subunits were detected at roughly 
the same electrophoretic mobility (Fig. 1 B, band VI). This differ-
ential pattern of migration may be infl  uenced by variable deter-
gent binding. Alternatively, DDM may be harsher than DIG and 
change subunit stoichiometry. It was reported that DDM disrupts 
the γ-secretase complex into subspecies (Fig. 1 B) (Fraering et al., 
2004). Two principal PS1 WT complexes of  440 kD (band VI) 
and  100–120 kD (band II) in DDM-solubilized microsomes 
represent a full complex (band VI) and a complex (band II) that 
contains PEN-2 and either PS1-NTF (N-terminal fragment) or 
PS1 FL (full length), respectively (Fig. 1 B, two left panels, lanes 
WT DDM) (Fraering et al., 2004). Band II was also observed in 
DDM-solubilized PS1 ∆E9 microsomes (Fig. 1 B two left panels, 
lanes ∆E9 DDM). Interestingly, the band II from PS1 WT and ∆E9 
microsomes showed similar electrophoretic mobility (Fig. 1 B, 
two left panels, DDM lanes), whereas the band VI from PS1 
Figure 2.  Packaging of the endogenous 𝗄-secretase 
complex into COPII vesicles. A cell line derived from 
Chinese hamster ovary (CHO-K1) was used for the 
transport vesicle formation assay. (A) Standard trans-
port vesicle formation assay. PS1 and NCT were found 
either as full-length (FL) or immature form in the vesicle 
fraction, respectively. (B) Microsomes were prepared 
from CHO-K1 cells, mouse embryonic stem cells (ES), 
and PS1/PS2 double knockout ES cells (PS null) and 
protein content was separated on 6% SDS-PAGE and 
analyzed by immunoblotting. (C) A large scale (1.5 ml) 
transport vesicle formation reaction was performed. 
Total and transport vesicle membranes were solubi-
lized with HN buffer containing 1% DIG, subjected to 
BN-PAGE and probed with anti-PS1 NTF antibody. 
PS1 FL was incorporated into a  440 kD complex 
(band VI) or into  250–300 kD complexes (band V). 
Band V was also recognized by anti-PS1-NTF anti-
body in CHO-K1 cells lysates but not in N2a cell 
lysates (Fig. 1 B)JCB • VOLUME 179 • NUMBER 5 • 2007  954
WT and ∆E9 microsomes showed a mobility difference of 
20–30 kD (Fig. 1 B). It is likely that the difference in electro-
phoretic migration of the apparently intact PS1 WT and PS1 
∆E9 complexes is a refl  ection of conformational alterations 
(Berezovska et al., 2005) or changes in subunit stoichiometry in-
duced by the deletion of exon 9 within the PS1∆E9 holoprotein.
To discover the biogenic origin of intact γ-secretase com-
plex, we solubilized membranes from microsomes and transport 
vesicles using 1% DIG and applied cleared soluble samples 
to blue-native gels. From the transport vesicle fraction, PS1 
was detected in a band migrating at a position (440 kD) character-
istic of the intact γ-secretase complex (Fig. 1 D) (Edbauer et al., 
2002; Kimberly et al., 2003). In addition, some PS1-containing 
subcomplexes were also found in the vesicle fraction (Fig. 1 D).
PS1 in the vesicle fraction and in the γ-secretase complex 
was mainly the full-length (FL) precursor form (Fig. 1, A and D). 
Apparently, association of minimal γ-secretase subunits (PS1, 
NCT, APH-1, and PEN-2) was not suffi  cient for effi  cient endo-
proteolysis of PS1. Perhaps another infl  uence(s) in a later compart-
ment governs PS1 endoproteolysis (see the PS1 is sorted by Sec24A 
section). From our results, it is clear that γ-secretase assembly 
occurs before or within COPII vesicles.
Packaging of the endogenous 𝗄-secretase 
complex
Overexpression of PS1 may bias formation of the γ-secretase 
complex in the ER or COPII vesicles. To test whether the 
endogenous level of PS1 leads to formation of γ-secretase, we 
used CHO-K1 cells where PS1 FL is relatively easily detectable 
(Kim et al., 2005). The vesicle fraction contained almost exclu-
sively PS1 FL and was enriched in a higher mobility form of 
NCT (Fig. 2 A). This higher mobility species of NCT predomi-
nated in PS1/2 null ES cells, thus it likely corresponds to the 
immature form (Fig. 2 B). When the vesicle fraction was ana-
lyzed by BN-PAGE to monitor γ-secretase, PS1 was found in 
band V and VI (Fig. 2 C), reinforcing the idea that normal levels 
of γ-secretase subunits assemble in an intact complex.
PS1 is sorted by Sec24A
We have previously reported that recombinant mammalian 
  COPII proteins, though functional in budding vesicles from 
synthetic liposomes, appear to be less active in budding trans-
port vesicles from ER membranes (Kim et al., 2005). A limiting 
cytosolic factor restores the activity of COPII proteins on ER 
membranes. This limitation was overcome in incubations con-
taining two- to threefold more than the normal level of ER 
membranes (semi-intact cells, SICs) (Fig. 3 A). To explore the 
COPII subunit preference for various cargo proteins, we puri-
fi  ed all four human Sec24 proteins in complex with Sec23A 
(23A/24A, 23A/24B, 23A/24C, and 23A/24D) and used them 
in reactions containing an elevated level of ER membrane 
material. As previously seen, the recombinant COPII proteins 
showed lower cargo packaging activity than cytosol even 
though  10-fold more COPII protein was added to the reac-
tions (Fig. 3 A). p58/ERGIC53/LMAN1 was captured preferen-
tially by Sec24A and Sec24D. APP was recognized by Sec24A, 
Sec24C, and Sec24D. In contrast, PS1 was favored by Sec24A, 
although Sec24B and Sec24D were marginally active in PS1 
packaging (Fig. 3 A)
PS1 packaging in authentic COPII vesicles should depend 
on all of the COPII components. Individual COPII components 
or combinations of two components did not show signifi  cant 
cargo packaging activity (Fig. 3 B). γ-Secretase packaging into 
Figure 3. Cargo  speciﬁ  city of Sec24 paralogues. (A and B) Transport vesi-
cle formation reactions were performed using either rat liver cytosol or 
recombinant COPII proteins with N2a APPswe PS1 WT cells. The ﬁ  nal 
concentration of Sar1, Sec23/24, and Sec13/31 was 5 μg/ml, respec-
tively. (C) Membranes were solubilized in HN buffer containing 1% DIG 
and the cleared lysates were applied to BN-PAGE. The contents of the gel 
were transferred into a PVDF membrane and probed with either anti-PS1-
NTF or anti-NCT antibody. γ-SECRETASE IN COPII VESICLES • KIM ET AL. 955
vesicles generated with purifi  ed COPII (including 23A/24A) 
proteins was evaluated in 1% DDM samples resolved on BN-
PAGE (Fig. 3 C). PS1 in the vesicle fraction was found in the 
γ-secretase complex (band VI) which also co-migrated with the 
NCT subunit (Fig. 3 C, left and right panels). Because Sec24 
appears to confer cargo specifi  city to the COPII coat (Miller 
et al., 2003; Mossessova et al., 2003), Sec24A may contain a 
recogni  tion site for one or more of the γ-secretase subunits.
We showed that even though γ-secretase formation oc-
curs in the ER or in COPII vesicles, PS1 is found predominantly 
as FL and suggested that PS1 endoproteolysis occurs at post 
ER compartments. This model suggests that if we block ex-
port of PS1 from the ER, PS1 should remain intact. To test 
this possibility, we used shRNA transfection to lower the 
le  vels of individual Sec24 paralogues (Fig. 4, A and B). A 90% 
reduction in Sec24A caused a 75% increase in the ratio of PS1 
Figure 4.  Sec24A knockdown delays PS1 matu-
ration.  (A) HEK 293 cells expressing human 
APP695 and PS1WT (HEK.APP.PS1 WT) were 
transiently transfected with 3 μg of shRNA speciﬁ  c 
for the four individual Sec24 paralogues or the 
empty vector (control) for 96 h. Cell lysates were 
analyzed for Sec24A, Sec24B, Sec24C, Sec24D, 
and Sec23A levels by immunoblotting. Each mem-
brane was probed for β-actin as a loading control. 
(B) Immunoblot signals derived from IRDye-labeled 
secondary antibodies were measured using the 
Odyssey IR Imaging System (LI-COR Biosciences). 
Protein levels of the corresponding Sec24 variants 
were normalized to that of β-actin. Speciﬁ  c reduc-
tion due to RNA interference was routinely less 
than 20% after 96 h shRNA treatment. (C) HEK.
APP.PS1 WT cells were transiently transfected with 
Sec24 paralogue-speciﬁ  c shRNA for 96 h as de-
scribed above. The full-length form of PS1 (PS1 FL) 
and the PS1 N-terminal fragment (PS1-NTF) levels 
were detected by immunoblot analysis using anti-
PS1-NTF antibody. (D) Quantiﬁ  cation of the matu-
ration level of PS1 FL into PS1-NTF using the 
Odyssey IR Imaging System after knockdown of in-
dividual Sec24 variants. The ratio of PS1 FL to 
PS1-NTF expressed as percentage of the empty 
vector control was shown. Error bars represent SD. 
*, P < 0.05 using t test. n = 3 or 4.JCB • VOLUME 179 • NUMBER 5 • 2007  956
FL/PS1-NTF (Fig. 4, C and D). Sec24C knockdown caused a 
reproducible but smaller (25%) reduction in PS1 maturation. 
Our results are consistent with the idea that PS1 endoproteolysis 
requires traffi  c to a downstream compartment(s).
In vitro maturation of 𝗄-secretase
Having established that γ-secretase assembly occurs before or 
within a COPII vesicle, we explored PS1 endoproteolysis as a 
surrogate marker of γ-secretase activity because only processed 
PS1 fragments bind γ-secretase inhibitors (Esler et al., 2000; 
Li et al., 2000; Seiffert et al., 2000; Beher et al., 2003). We solu-
bilized a total membrane fraction in 0.5% CHAPSO lysis buffer, 
incubated cleared lysate fractions at 37°C for 0–3 h, and ana-
lyzed PS1 maturation by SDS-PAGE. PS1-NTF was generated 
within 1 h of incubation at pH 6.5, suggesting that a slightly 
acidic environment is optimal for endoproteolysis of PS1 
(Fig. 5 A). A concurrent increase of newly generated PS1-CTF 
was not observed (Fig. 5 A). Perhaps PS1-CTF was generated 
quickly and then degraded such that it did not accumulate 
during the incubation.
We then examined PS1 maturation in enriched COPII 
vesicles (Fig. 5, B and C). We prepared CHAPSO lysates us-
ing COPII vesicles generated from N2a cells overexpressing 
PS1 (Fig. 5 B; Vesicle), from CHO-K1 cells containing en-
dogenous level of γ-secretase subunits (Fig. 5 C; K-1) or from 
γ-30 cells overexpressing PS1, NCT, PEN-2, and APH-1a 
(Fig. 5 C; γ-30) (Kimberly et al., 2003). Little if any PS1 pro-
teolysis was observed in these samples. Our results suggest 
that the apparently intact γ-secretase complex formed in ER is 
not enzymatically competent. Traffi  c  of  γ-secretase to the 
Golgi may provide an environment (pH, ionic) conducive to 
endoproteolysis or expose the complex to another protein that 
promotes endoproteolysis.
Quality control at the ER exit site
Over 100 FAD-linked PS mutations have been found through-
out the PS molecule, especially in PS1 (Alzheimer Disease and 
Frontotemporal Dementia Mutation database; http://www
.molgen.ua.ac.be/ADMutations). Many of these mutations af-
fect the folding of PS1 (Berezovska et al., 2005), and yet the 
mutant proteins promote aberrant APP processing in the secre-
tory stations subsequent to the ER. It is reasonable to assume 
that these mutant proteins fold suffi  ciently well to pass ER 
quality control inspection. Because ER export is a benchmark 
of underlying ER quality controls, we directly monitored exit 
of these mutant proteins from the ER using in vitro COPII ves-
icle formation assay. We used microsomes derived from N2a 
cell lines stably expressing human APP695swe, a FAD-linked 
APP variant, and human PS1 variants (Fig. 6, A and B). To ac-
count for differences in cargo packaging between experiments, 
we normalized the packaging effi  ciency of each cargo mole-
cule to that of p58 in the same reaction (Fig. 6, B and D). As we 
showed earlier using microsomes from CHO-K1 cells (Fig. 2 A), 
WT PS1 was found mainly as a full-length form in the trans-
port vesicle fractions (Fig. 6). PS1 ∆E9, a deletion of exon 9 
isolated from a family with early onset AD (Crook et al., 1998), 
showed reduced packaging into COPII vesicles. PS1 D385A, 
a putative active site mutant, showed a partial defect in the 
packaging PS1. In all cases, p58 packaging was normal, thus 
the PS1 ∆E9 packaging defect was cargo selective.
We considered the possibility that the APP695swe muta-
tion may contribute to the abnormal traffi  cking PS1. To test 
this idea, we prepared microsomes from N2a cell lines stably 
expressing human wild-type APP695 and one of three human 
PS1 variants. Packaging defects for PS1 ∆E9 and PS1 M146L, 
another FAD-linked PS1 mutation, were obvious although PS1 
∆E9 displayed a more pronounced lesion (Fig. 6, C and D). 
One other PS1 allele, C410Y, was not detectably different from 
WT (unpublished data). We conclude that two FAD-linked 
PS1 mutations, ∆E9 and M146L, are suffi  ciently defective to 
impose a quality control delay in ER export of the misfolded 
forms of PS1.
Figure 5.  In vitro PS1 maturation. (A) Permeabilized lysates derived from 
N2a cells expressing PS1 were solubilized in MNM buffers containing 
0.5% CHAPSO at different pHs. Ribophorin I was also probed as a load-
ing control. (B) CHAPSO lysates were prepared from N2a SICs expressing 
PS1 (SIC) and from COPII vesicles generated from the same cells (Vesicle) 
(800 μl reaction). Ribophorin I was also probed as a loading control. 
(C) CHAPSO lysates were prepared from COPII vesicles generated from 
CHO-K1 cells (K-1) and from γ-30 cells expressing PS1, PEN-2, APH-1a, 
and NCT (γ-30) (800 μl reaction).γ-SECRETASE IN COPII VESICLES • KIM ET AL. 957
Incorporation of newly synthesized PS1 
into the transport vesicle
To explore the earliest events in the synthesis, folding and pack-
aging of wild-type and mutant PS1, we adapted our budding 
reaction to measure the incorporation of membrane proteins 
synthesized and assembled in vitro. A proof of principle is shown 
in Fig. 7 A (left) in which both p58 and ribophorin I proteins 
were synthesized and translocated into permeabilized cells. 
Packaging of radiolabeled p58 into COPII vesicles was prevented 
by incubation with the dominant-negative Sar1a H79G. A low level 
of newly synthesized ribophorin I was released in the vesicle 
fraction in an incubation with or without Sar1a H79G. This was 
not observed for steady-state ribophorin I levels analyzed by 
immunoblot on the same PVDF membrane (Fig. 7 A, top panels). 
Importantly, radiolabeled wild-type PS1 was packaged into 
COPII vesicles, although less effi  ciently than p58 (Fig. 7 A, right).
We quantifi  ed the effi  ciency of wild-type and mutant PS1 
protein export comparing radiolabel signal in ER membrane 
pellet and vesicle fractions (Fig. 7 B, middle and bottom). 
Quantifi  cation showed that PS1 ∆E9 export was reduced almost 
Figure 6.  Defective packaging of FAD-linked 
PS1 variants into transport vesicles. Transport 
vesicle formation reactions were performed us-
ing microsomes derived from N2a cells stably 
expressing human APP695swe and human 
PS1 variants (A and B) or N2a cells stably ex-
pressing human APP695wt and human PS1 
variants (C and D). See Materials and methods 
for details. Proteins were visualized using 
35S-labeled secondary antibody (A) or using pro-
tein A-HRP conjugate for ECL-Plus (Amersham 
Biosciences) (C). Cyt represents cytosol (4 mg/ml) 
and Nuc represents an ATP regenerating sys-
tem and GTP. Error bars represent SD. *, 
P < 0.001; **, P < 0.05; ***, P < 0.01 using 
t test. n = 5 or 6.JCB • VOLUME 179 • NUMBER 5 • 2007  958
to background levels, whereas PS1 M146L displayed an inter-
mediate defect (Fig. 7 C). The export of FAD mutants PS1 
E280A and C410Y was comparable to wild-type levels. From 
these results we concluded that the export defects of newly syn-
thesized PS1 ∆E9 and PS1 M146L are comparable to the export 
defects observed in N2a cells stably expressing these FAD-linked 
mutant proteins as shown in Fig. 6. Thus, the defect is not the 
result of overexpression of a mutant protein.
A chemical chaperone, TMAO, partially 
restores packaging of PS1 𝖫E9
Protein misfolding accounts for aberrant export of mutant cystic 
fi  brosis transmembrane conductance regulator (CFTR) molecules 
from the ER (Cheng et al., 1990; Gelman and Kopito, 2002; 
Sanders and Myers, 2004). Impaired traffi  cking of CFTR 
∆F508 is partially rescued by incubating cells with media con-
taining chemical chaperones such as glycerol and trimethyamine 
Figure 7.  Reduced COPII export of newly synthesized 
FAD mutant PS1 M146L and PS1 𝖫E9. (A) Both ribophorin I 
(RI) and p58 (left) or PS1 (right) proteins were translated 
in vitro and translocated into the ER membranes of semi-
intact N2a cells (SICs). The SICs containing the radio-
labeled proteins were harvested and supplemented with 
components to reconstitute COPII budding. Differential 
centrifugation separated SIC-ER pellet (input) from the COPII 
vesicles budded from the ER. After ﬁ  rst analyzing the con-
trols for ER export (Ribophorin I and p58) at steady-state 
levels using immunoblot (IB) analysis, the PVDF mem-
branes were dried and exposed to ﬁ  lm and a Phosphorscreen 
to analyze the radiolabeled proteins. (B) Same as in (A) 
but for wild-type PS1 and several FAD mutant proteins. 
Lanes indicated with an asterisk indicate the ER pellet frac-
tion (input). (C) Quantiﬁ   cation of wild-type PS1 export 
and FAD mutant proteins (see Materials and methods). 
The nonspeciﬁ  c leakage (-rATP, vesicle fractions) was sub-
tracted from the COPII export from ER samples 
(+rATP,vesicle fractions). Only M146L and ∆E9 showed a 
signiﬁ  cant difference compared with WT (*, P < 0.05; 
**, P < 0.001 using t test. n = 4 to 7).γ-SECRETASE IN COPII VESICLES • KIM ET AL. 959
N-oxide (TMAO) (Brown et al., 1996; Sato et al., 1996; Qu et al., 
1997; Bennion and Daggett, 2004). To test the idea that the 
export defect of PS1 ∆E9 is due to misfolding, we performed 
a transport vesicle formation assay in the presence of increas-
ing concentrations of TMAO (Fig. 8). In addition, to be certain 
that our reactions recapitulate COPII vesicle formation, we per-
formed control reactions supplemented with a purifi  ed dominant-
negative Sar1a H79G, to specifi  cally inhibit the generation of 
COPII vesicles. Packaging of PS1 ∆E9 was increased signifi  cantly 
by addition of TMAO in a concentration-dependent manner 
(Fig. 8, B and C). The packaging of WT PS1 was only marginally 
enhanced by TMAO (Fig. 8, A and C). These results are consistent 
with the notion that the underlying cause of the traffi  cking defect 
is at least partly due to protein misfolding. Because TMAO did 
not fully repair the packaging defect of PS1 ∆E9, it is possi-
ble that the exon 9 region may contain export information.
Next, we tested the effect of TMAO on the packaging of 
the γ-secretase complex bearing PS1 ∆E9. Because addition of 
62.5 mM TMAO in the reaction enhanced the overall budding 
effi  ciency, we compared 62.5 mM TMAO and 250 mM TMAO 
conditions where only packaging of PS1 differed (Fig. 8 B, com-
pare 0 and 62.5 mM TMAO conditions). Little or no complex 
was detected in transport vesicles produced from ∆E9 micro-
somes at 62.5 mM TMAO condition as expected. Packaging of 
apparently intact γ-secretase complex was enhanced by 250 mM 
TMAO from ∆E9 microsomes, whereas packaging of the WT 
complex was essentially unaffected (Fig. 9, A and B). This result 
suggests that rescued PS1 ∆E9 is incorporated into the complex.
Discussion
We report that an apparently immature γ-secretase complex 
containing intact PS1 is captured in ER-derived COPII vesicles 
through the intervention of the sorting subunit Sec24A. In vitro 
PS1 maturation assays suggest that endoproteolysis occurs later 
in an acidic compartment(s) after a conformational change. 
Two FAD-linked PS1 alleles, ∆E9 and M146L, retard the pack-
aging of PS1 and the γ-secretase complex. A chemical chaper-
one, TMAO, restores packaging of PS1 ∆E9, suggesting that this 
defect is partly due to protein misfolding. Because ER-  retained 
γ-secretase is enzymatically incompetent, ER retention of the 
complex, per se, cannot directly infl  uence cleavage preference 
either at the Aβ40 or Aβ42 site.
COPII cargo recognition and sorting is achieved in large 
measure by the Sec24 subunit (Miller et al., 2003; Mossessova 
et al., 2003). Mammalian cells have four Sec24 variants 
(Sec24A, B, C, and D), which show partially overlapping cargo 
preferences. Despite this redundancy, PS1 showed preference 
for Sec24A in vitro and in cultured cells (Fig. 3 and Fig. 4). This 
cargo preference suggests that there will be other cargo proteins 
whose export from the ER depends solely on a particular Sec24 
protein. In yeast, Pma1 export depends on Lst1, a Sec24 para-
logue (Roberg et al., 1999; Shimoni et al., 2000). The expres-
sion pattern of Sec24 proteins may vary in cell types and during 
developmental stages. Therefore, spatiotemporal regulation of 
expression of Sec24 paralogues may be coupled with expres-
sion of PS1 to facilitate development.
Membrane protein mutations are a common cause of 
human disease. In the case of cystic fi  brosis conductance regula-
tor (CFTR), over 1,200 cystic fi  brosis (CF)–causing mutations 
have been classifi  ed (Gelman and Kopito, 2002): class I mutations 
Figure 8.  TMAO enhances packaging of PS1 𝖫E9 into COPII vesicles. 
(A and B) Microsomes were washed with reaction buffer containing the in-
dicated concentrations of TMAO. Sorbitol was omitted in the buffer to accen-
tuate the effect of TMAO. Vesicle formation reactions were performed in 
the presence of TMAO as indicated. Sar1a H79G (10 μg/ml) was added 
to the reaction where indicated. Proteins were separated by SDS-PAGE 
and visualized by ECL-plus. (C) For quantiﬁ  cation, 
35S-labeled secondary 
antibody was used as described in the legend of Fig. 1. Although the bud-
ding efﬁ  ciency of PS1 WT and ∆E9 is quite different at 0 mM TMAO, it is 
set to 100% to contrast the effect of TMAO on the two proteins. Error bars 
represent SD. *, P < 0.01; **, P < 0.05 using t test. n = 3.JCB • VOLUME 179 • NUMBER 5 • 2007  960
abrogate synthesis of the CFTR protein, class II mutations cause 
defective protein traffi  cking, class III mutations lead to unstable 
or nonfunctional protein at the cell surface, and class IV mutations 
interfere with channel activation and regulation by physiological 
agonists. The CFTR ∆F508 mutation, which causes misfolding 
and arrests traffi  c in the ER, is the most common human allele 
(more than 90%) (Kerem et al., 1989; Riordan et al., 1989). 
The CFTR ∆F508 mutation was initially believed to affect traffi  ck-
ing alone (for review see Gelman and Kopito, 2002). However, 
the folding defect also produces an abnormal response to 
β-  adrenergic agonists and instability at the plasma membrane. 
Incubation of cells expressing CFTR ∆F508 in a medium 
contain  ing osmolytes such as glycerol and TMAO increases the 
steady-state localization of functional CFTR ∆F508 in the 
plasma membrane (Brown et al., 1997). Unfavorable interaction 
between osmolytes and the peptide backbone favors the folded 
state in normal and misfolded mutant proteins (Bolen and 
Baskakov, 2001). The effect of TMAO on traffi  c of the PS1 ∆E9 
mutant protein resembles the behavior of CFTR ∆F508 mutant 
protein, thus PS1 misfolding causes pleiotropic effects such as a 
traffi  cking defect and abnormal processing of APP.
Misfolded proteins in the ER are subjected to quality con-
trol and in severe cases to ER associated degradation (ERAD) 
(Römisch, 2005). Although the deletion mutant PS1 ∆E9 is pro-
foundly defective in ER export, the mutant protein is as stable 
as PS1 WT (Ratovitski et al., 1997). In fact, the steady-state 
distribution of PS1 ∆E9 is only mildly different from that of 
PS1 WT (Kim et al., 2000). Although the ∆E9 mutant protein is 
substantially defective in sorting into COPII vesicles in vitro, 
this delay is overcome with time and the mutant protein is even-
tually targeted to later compartments. Delays at later stations 
may have a direct bearing on the misprocessing of APP in cells 
harboring ∆E9 or other FAD mutant proteins.
Previous studies suggest that formation of the γ-secretase 
complex can occur in the ER (Kim et al., 2004; Capell et al., 2005). 
These studies used a recombinant NCT construct with an 
ER-retrieval motif (KKXX) inserted into the cytosolic portion 
of NCT in order to retain NCT in the ER. In cells in which the 
normal NCT was down-regulated, the ER-retained NCT was 
incorporated into the γ-secretase complex and generated Aβ at 
a normal level, suggesting that the active γ-secretase complex 
formation can happen in the ER. However, because the ER-
retrieval signal exerts its effect through retrieval rather than 
inhibition of ER export, it is not clear where activation of the 
γ-secretase complex occurs. For example, it is possible that 
γ-secretase is assembled and activated in the ERGIC or in the 
cis-Golgi and retrieved back to ER. In our study, we monitored 
the content of ER derived vesicles   directly. In addition, normal 
levels of endogenous PS1 were detected in the γ-secretase com-
plex packaged in ER-derived vesicles.
We discovered that complex formation and activation of this 
proteolytic enzyme are discrete processes. A conformational change 
and an acidic environment may be critical requirements for matura-
tion of γ-secretase under normal conditions. Our data suggest that 
this process occurs at a post-ER compartment(s). Consistent with 
this model, it is reported that the ER form of NCT is sensitive for 
trypsin treatment whereas complex glycosylated NCT is resistant 
(Shirotani et al., 2003). Our results indicate that an acidic environ-
ment is not suffi  cient for γ-secretase activation.
Retention of mutant γ-secretase in the ER may have direct 
or indirect consequences that infl  uence the development of AD. 
For example, PS1 may serve as a Ca
2+ leak channel in the ER. 
Disturbance of Ca
2+ homeostasis in cells expressing the two 
FAD-linked PS1 mutations (∆E9 and M146V) may be the 
consequence of ER retention (Tu et al., 2006; Nelson et al., 
2007). Alternatively, in light of the recent fi  nding that PS has 
a γ-secretase–independent function in cytoskeletal organization, 
it is also possible that an ER export delay of γ-secretase or PS1 
may disturb cytoskeleton-mediated traffi  c at later compartments 
(Khandelwal et al., 2007).
Figure 9.  TMAO rescues packaging of the 𝗄-secretase complex containing PS1 𝖫E9. N2a APPswe PS1 WT or PS1 ∆E9 cells were used. (A and B) Trans-
port vesicle formation reactions were performed and membrane fractions were analyzed by BN-PAGE as indicated in the legend of Fig. 3. Membranes 
were solubilized in HN buffer containing 1% DIG. Polyclonal anti-PS1 NTF antibody was used to detect PS1.γ-SECRETASE IN COPII VESICLES • KIM ET AL. 961
Our results suggest a model in which γ-secretase is as-
sembled in the ER and activated in a downstream acidic com-
partment. A delay in ER export of the γ-secretase complex may 
play a role in the disruption of cell physiology.
Materials and methods
Antibodies
Antibodies were used as described earlier (Kim et al., 2005). Antibodies 
were diluted as follows: anti-Sec24A antibody, 1:1,000; anti-Sec24B anti-
body, 1:1,000; anti-Sec24C antibody, 1:1,000; anti-Sec24D antibody, 
1:1,000; anti-Sec23 antibody, 1:1,000; anti-actin C4 antibody (Mab), 
1:20,000 (MP Biomedicals); anti-PS1 NTF (Ab14), 1:10,000 (a gift from 
Sam Gandy, Farber’s Institute of Neuroscience, Philadelphia, PA); anti-
NCT antibody (Guinea pig), 1:2,000 (Chemicon); mouse monoclonal anti-
NCT antibody (9C3), 1: 7,000; mouse monoclonal anti-PEN-2 antibody 
(7D3), 1:9,000; polyclonal anti-APH1a antibody (B80.2), 1:1,000. Anti-
NCT antibody, anti-PEN-2 antibody, and anti-APH1a antibodies were gifts 
from W. Annaert (Center for Human Genetics, Leuven, Belgium).
Plasmid constructions
The human Sec24A coding region was ampliﬁ   ed from MGC-12985 
(ATCC) using synthetic oligonucleotides JK108 (5′-CCTTCCAACCCCAT-
GGGAATGTCCCAGCCGGGAATACCGGCC-3′) and JK109 (5′-TTTTTTTT-
GTGCGGCCGCAAATTTTATTTCACATTAAGTCAGTAT-3′). The ampliﬁ  ed 
fragments were digested with NcoI and NotI and inserted into correspond-
ing sites of pHis-hSec24C to replace Sec24C with Sec24A. The resultant 
plasmid, pJK13s, has a His6 tag at the N terminus, and the C-terminal re-
gion is truncated. To construct the full-length Sec24A, we digested pJK13s 
and pBS-hSec24A (J.-P. Paccaud) with StuI and XhoI. The StuI- and XhoI-
  digested fragment from pBS-hSec24A containing an intact Sec24A C-terminal 
region was inserted into the corresponding site of pJK13s to generate a 
full-length human Sec24A (pJK13). The sequence of this resultant Sec24A 
is identical to AAH19341.
The human Sec24B coding region was ampliﬁ  ed from pCiNeo-Flag-
human Sec24B using synthetic oligonucleotides JK110 (5′-TACAAAGAC-
GCCATGGGAATGTCGGCCCCCGCCGGGTCCTCTCAC-3′) and JK111 
(5′-GTCTGCTCGAAGCATTAACCCTCA-3′). The ampliﬁ  ed fragments were 
digested with NcoI and NotI and inserted into corresponding sites of 
pHis-hSec24C to replace Sec24C with Sec24B. This plasmid, pJK14, has 
a His6 tag at the N terminus.
The human Sec24D coding region was ampliﬁ   ed from MGC-
46092 (ATCC) using synthetic oligonucleotides JK114 (5′-TGGAATG-
ATAGAATTCAAATGAGTCAACAAGGTTACGTGGCTACA-3′) and JK113 
(5′-TTTTTAAGAGCGGCCGCAGTGATTTATTGATACTGGTTAACA-3′). The 
ampliﬁ  ed fragments were digested with EcoRI and NotI and inserted into 
corresponding sites of pHis-hSec24C to replace Sec24C with Sec24D. 
This plasmid, pJK15, has a His6 tag at the N terminus.
Plasmids pHis-hSec24C, pJK13, pJK14, and pJK15 are derivatives 
of pFastBac HTb (Invitrogen) suitable for baculoviral manipulation.
Expression and puriﬁ  cation of proteins
Rat liver cytosol was prepared as described previously (Kim et al., 2005). 
Hamster SarA2 (previously known as Sar1a) protein, Sec23A/24, and 
Sec13/31A complexes were also puriﬁ  ed as described previously (Kim 
et al., 2005). Sf9 cells infected with either Sec23A/His6Sec24C or Sec13/
His6Sec31A viruses were lysed by sonication in a lysis buffer [20 mM 
Hepes (pH 8.0), 500 mM KOAc, 250 mM sorbitol, 10% glycerol, 10 mM 
imidazole, 0.1 mM EGTA, and 5 mM β-mercaptoethanol] supplemented 
with a protease inhibitor cocktail tablet (1×, Roche). The lysate was cleared 
by successive centrifugation in a Sorvall SS34 rotor for 30 min at 15,000 
rpm and in a Beckman 45 Ti rotor for 1 h at 40,000 rpm. The cleared lysate 
was incubated with prewashed Ni-agarose resin for 1 h at 4°C and poured 
into a column. The column was washed ﬁ  rst with lysis buffer and washing 
buffer (lysis buffer with 50 mM imidazole) and then with elution buffer (lysis 
buffer with 250 mM imidazole). Eluates were pooled, distributed into small 
aliquots, snap frozen in liquid nitrogen, and kept at −80°C.
Cell culture
N2a cells stably expressing human APP695 were transfected with pAG3-
PS1WT, or pAG3-PS1M146L or pAG3-PS1∆E9 plasmid and selected in a 
medium containing 50% DME, 50% OptiMEM, and 5% FBS supplemented 
with 200 μg/ml G418 and 400 μg/ml zeocin. N2a cells were transfected 
with pAG3-PS1WT or pAG3-PS1∆E9 plasmid and selected in a medium 
containing 50% DME, 50% OptiMEM, and 5% FBS supplemented with 
400 μg/ml zeocin. Colonies derived from single cells were screened for 
similar levels of PS1 expression ( 15-fold more than endogenous mouse 
PS1, probably an overestimation because anti–human PS1 NTF antibody 
was used to quantify signals). Human embryonic kidney (HEK 293) cells 
stably expressing human APP695 (HEK.APP) were maintained in DME sup-
plemented with 1× NEAA, 10% FBS, and 400 μg/ml G418. HEK 293 
cells stably expressing both human APP695 and PS1WT (HEK.APP.PS1 
WT) were maintained in DME supplemented with 1× NEAA, 10% FBS, 
550 μg/ml G418, and 400 μg/ml hygromcyin. CHO-K1 cells were main-
tained as described previously (Kim et al., 2005). γ-30 cells were a gift 
from Dr. Michael Wolfe (Harvard Medical School, Boston, MA).
In vitro vesicle-formation assay
Microsomes, rat liver cytosol, and recombinant COPII proteins were pre-
pared as described previously (Kim et al., 2005). A microsome suspension 
(30 μl) was mixed in 500 μl reaction buffer for the measurement of absor-
bance (600 nm). Normally, at an A600 = 0.025, 30 μl of the original 
  microsome suspension was used for a 100-μl budding reaction. When 
semi-intact cells (SICs) were used instead of microsomes, a suspension 
(5 μl) was mixed in 500 μl reaction buffer for the measurement of absor-
bance (600 nm). Normally, at an A600 = 0.02, 5 μl of the original SIC 
suspension was used for a 100-μl budding reaction. For most samples, 
20% of total membranes and 75% of a transport vesicle fraction were 
loaded into a well. Proteins were resolved by SDS-PAGE and transferred to 
PVDF membranes. Membrane strips were probed with appropriate pri-
mary antibodies and 
35S-labeled secondary antibody, then quantiﬁ  ed and 
visualized using a Phosphorimager. Radioactive signals were measured to 
calculate the budding/packaging efﬁ  ciency of each cargo molecule based 
on total input and the efﬁ  ciency of a cargo protein was normalized to the 
budding efﬁ  ciency of p58. Because PS1∆E9 and PS1D385A are not pro-
cessed into N-terminal and C-terminal fragments (NTF and CTF), we 
summed the signals of full-length (FL) form and NTF when calculating the total 
input of PS1WT and PS1M146L for comparison.
In vitro PS1 endoproteolysis assay
The procedure to make SICs has been described (Wilson et al., 1995). 
100 μl of standard SICs (see in vitro vesicle-formation assay section) were 
centrifuged and the pellet was solubilized in a 100 μl MNM (50 mM MES, 
pH 6.5, 150 mM NaCl, and 5 mM MgOAc) buffer containing 0.5% 
CHAPSO. The lysate was cleared by centrifugation at 100,000 g for 30 min. 
The supernatant was sampled into three tubes (15 μl each) and incubated 
at 37°C as indicated. After the reaction, samples were analyzed by SDS-
PAGE and immunoblotting.
In vitro tranlation, translocation, and budding reaction
The procedure to make SICs and the subsequent in vitro translation reac-
tions have been described (Wilson et al., 1995). After translating the pro-
teins for 45 min at 30°C, 0.75 ml ice-cold KHM buffer (110 mM KOAc, 
20 mM Hepes, pH 7.2, and 2 mM Mg(OAC)2) was added to stop the 
translation reaction and the SICs were harvested at 3,000 g for 3 min at 
4°C. The SICs were resuspended in 20 μl KHM and aliquoted before as-
sembling the budding reaction as described above. To calculate the per-
centage of budding, we correlated the radiolabeled signal in the vesicle 
fractions (both −rATP and +rATP) to the radiolabeled signal in the ER pel-
let fractions of each translated protein. Nonspeciﬁ  c leakage found in the 
vesicle fractions from budding reactions without ATP regeneration mix 
(−rATP) was subtracted from radiolabeled signal found in vesicle fractions 
from budding reactions with ATP regeneration mix (+rATP).
Blue-native PAGE
Membranes were solubilized with HN buffer containing 50 mM Hepes 
(7.0), 50 mM NaCl, and appropriate detergents for 30 min at 4°C. Lysates 
were centrifuged for 30 min at 65,000 rpm in a Beckman TLA100.3 rotor 
and separated on 4–12.5% polyacrylamide gradient gels (18 cm × 16 cm × 
1.5 mm) with high molecular weight markers from Amersham Biosciences 
(Schägger and von Jagow, 1991).
RNA interference
The coding regions of human Sec24A, Sec24B, Sec24C, and Sec24D were 
used to design short hairpin RNA (shRNA) constructs for speciﬁ  c gene silenc-
ing of the corresponding Sec24 isoforms using the siRNA Target Finder 
software from Ambion (http://www.ambion.com/techlib/misc/siRNA_
ﬁ  nder.html). The shRNA target sequences for individual human Sec24 
isoforms were as follows: 5′-AGGAGATGGAAGTGTAACT-3′ (Sec24A),JCB • VOLUME 179 • NUMBER 5 • 2007  962
5′-GGCATTGGTACCGTGTTAT-3′ (Sec24B), 5′-TGTAGCTTCTC  A  G  T  T  CACT-3′ 
(Sec24C), and 5′-CCCTTTACAAATACAACAA-3′ (Sec24D). Custom-made 
62-nt DNA oligonucleotides were designed to contain a 19-nt sense strand 
target sequence that was linked to the 19-nt reverse complement anti  sense 
sequence by a short spacer region (5′-TTCAAGAGA-3′), followed by the 
RNA polymerase III termination sequence (5′-TTTTTT-3′), with the addition of 
BglII and BamHI restriction enzyme sites ﬂ  anking the 5′ and 3′ ends, respec-
tively. A pair of complementary oligonucleotides for each Sec24 target was 
synthesized (Integrated DNA Technologies), as follows: 5′-GATCAGGAG-
ATGGAAGTGTAACTTTCAAGAGAAGTTACACTTCC  ATCTCCTTTTTTT  GG-
AAA-3′ and 5′-AGCTTTTCCAAAAAAAGGAGATGG  AAGTGTAACTTCTC-
TTGAAAGTTACACTTCCATCTCCT-3′ for Sec24A;5′-GATCGGCATTGGTA-
CCGTGTTATTTCAAGAGAATAACACGGTACCAATGCCTTTTTTGGAAA-3′ 
and 5′-AGCTTTTCCAAAAAAGGCATTGGTACCGTGTTATTCTCTTGAAA-
TAACACGGTACCAATGCC-3′ for Sec24B; 5′-GATCTGTAGCTTCTCAGT-
TCACTTTCAAGAGAAGTGAACTGAGAA  GCTACATTTTTTGGAAA-3′ and 
5′-AGCTTTTCCAAAAAATGTAGCTTCTCAGTTCACTTCTCTTGAAAGTG-
AACTGAGAAGCTACA-3′ for Sec24C; 5′-GATCCCCTTTACAAATACAA-
CAATTCAAGAGATTGTTGTATTTGT  AA  AG  GGTTTTTTGGAAA-3′ and 5′-AGC-
TTTTCCAAAAAACCCTTTACAAATACAACAATCTCTTGAATTGTTG  TATTT-
GTAAAGGG-3′ for Sec24D.The complementary pair of DNA oligonucleotides 
was annealed and ligated into the linearized pSUPER.retro.puro shRNA ex-
pression vector (OligoEngine) in between the BglII and HindIII sites. This shRNA 
vector is expressed under the control of a human H1 RNA polymerase III 
promoter, to direct the synthe  sis of small RNA transcripts that can fold into 
short hairpin structure.
HEK.APP and HEK.APP.PS1 WT cells were transiently transfected 
with 3 μg of either pSUPER.retro.puro-Sec24 constructs or pSUPER.retro.
puro empty vector as control using Lipofectamine 2000 transfection reagent 
(Invitrogen) according to the manufacturer’s instructions. Cell lysates were 
harvested at 96 h post-transfection in cold lysis buffer [50 mM Tris (pH 7.5), 
150 mM NaCl, 5 mM EDTA, 1% Nonidet P-40, 0.1% SDS, and 1 mM 
PMSF] supplemented with protease inhibitor cocktail tablet (Roche). Equal 
amounts of total proteins were analyzed by SDS-PAGE and immunoblotting. 
Membranes were probed with the appropriate primary antibodies and 
IRDye labeled secondary antibodies, then visualized and quantiﬁ  ed using the 
LI-COR Odyssey IR Imaging System (LI-COR Biosciences). The level of β-actin 
was used as a loading control for each membrane.
Online supplemental material
Figure S1 shows packaging of endogenous cargo proteins from CHO-K1 
microsomes. Figure S2 shows that anti-PS1-NTF antibody speciﬁ  cally rec-
ognizes PS1 derivatives. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200709012/DC1.
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